| abstract |
(57) [Summary] [Object] To provide a peptide having angiotensin converting enzyme inhibitory activity. [Structure] A peptide having the following sequence (I) corresponding to residues 20 to 25 of the amino acid sequence of κ-casein glycomacropeptide. Ile-Ala-Ser-Gly-Glu-Pro (I) [Effect] Since this peptide has angiotensin converting enzyme (ACE) inhibitory activity and blood pressure lowering action, it is an active ingredient of ACE inhibitors and blood pressure lowering agents. Is useful as |